Most sold healthcare stocks in Q2 2020
See which Healthcare stocks institutional investors trimmed or exited the most in Q2 2020, measured as net reductions in reported share positions from Q1 2020 into Q2 2020. Notable reductions at the top of this list include BRISTOL-MYERS SQUIBB CO (BMY), BOSTON SCIENTIFIC CORP (BSX), ASTRAZENECA PLC-SPONS ADR (AZN), SANOFI-ADR (SNY). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| BMY | BRISTOL-MYERS SQUIBB CO | -30,025,105 | -$1.43B | 1 | 4 | 11 | 1 | 17 |
| BSX | BOSTON SCIENTIFIC CORP | -12,494,431 | -$357.27M | 1 | 3 | 3 | 0 | 7 |
| AZN | ASTRAZENECA PLC-SPONS ADR | -11,487,704 | -$330.50M | 2 | 0 | 2 | 0 | 4 |
| SNY | SANOFI-ADR | -8,464,613 | -$78.00M | 2 | 0 | 1 | 1 | 3 |
| GILD | GILEAD SCIENCES INC | -8,341,246 | -$560.59M | 1 | 1 | 8 | 3 | 11 |
| AVTR | AVANTOR INC | -7,619,002 | -$61.38M | 3 | 0 | 1 | 1 | 4 |
| CNC | CENTENE CORP | -6,921,127 | -$337.19M | 0 | 2 | 1 | 4 | 3 |
| BAX | BAXTER INTERNATIONAL INC | -6,834,211 | -$550.46M | 1 | 4 | 3 | 0 | 9 |
| MRK | MERCK & CO. INC. | -5,227,652 | -$369.32M | 1 | 5 | 10 | 2 | 19 |
| PFE | PFIZER INC | -5,106,115 | -$162.30M | 1 | 6 | 6 | 3 | 13 |
| CVS | CVS HEALTH CORP | -4,978,632 | -$212.67M | 1 | 4 | 7 | 1 | 16 |
| RHHBY | ROCHE HOLDINGS LTD-SPONS ADR | -4,976,619 | -$201.90M | 0 | 0 | 0 | 1 | 0 |
| BHC | BAUSCH HEALTH COS INC | -4,843,890 | $10.17M | 0 | 1 | 2 | 0 | 4 |
| NVS | NOVARTIS AG-SPONSORED ADR | -4,105,807 | -$200.29M | 0 | 0 | 7 | 2 | 8 |
| A | AGILENT TECHNOLOGIES INC | -3,424,710 | $82.32M | 0 | 2 | 1 | 3 | 5 |
| AMGN | AMGEN INC | -2,682,774 | -$462.27M | 1 | 4 | 4 | 1 | 11 |
| AKBA | AKEBIA THERAPEUTICS INC | -2,452,279 | $105.81M | 1 | 0 | 1 | 0 | 3 |
| UNH | UNITEDHEALTH GROUP INC | -2,200,402 | $432.86M | 4 | 8 | 10 | 1 | 23 |
| ELV | ELEVANCE HEALTH INC | -2,088,558 | -$206.29M | 0 | 5 | 3 | 3 | 10 |
| HOLX | HOLOGIC INC | -1,640,025 | $38.08M | 0 | 1 | 3 | 1 | 4 |
| VXRT | VAXART INC | -1,557,400 | $1.61M | 0 | 0 | 1 | 0 | 1 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | -1,519,205 | $26.72M | 2 | 1 | 2 | 2 | 5 |
| GRFS | GRIFOLS SA-ADR | -1,215,483 | -$47.94M | 0 | 0 | 2 | 0 | 2 |
| PRGO | Perrigo Company PLC | -1,192,120 | -$39.35M | 2 | 1 | 1 | 1 | 4 |
| VRTX | VERTEX PHARMACEUTICALS INC | -1,054,572 | $58.76M | 1 | 2 | 1 | 0 | 4 |
| IQV | IQVIA HOLDINGS INC | -1,016,610 | -$16.19M | 1 | 1 | 3 | 0 | 5 |
| HUM | HUMANA INC | -990,495 | $47.70M | 1 | 1 | 3 | 0 | 5 |
| LNTH | LANTHEUS HOLDINGS INC | -885,989 | -$10.73M | 0 | 0 | 1 | 0 | 1 |
| SEM | SELECT MEDICAL HOLDINGS CORP | -846,400 | -$12.81M | 0 | 0 | 1 | 0 | 1 |
| MOH | MOLINA HEALTHCARE INC | -819,952 | $65.06M | 1 | 0 | 2 | 0 | 3 |
| HRTX | HERON THERAPEUTICS INC | -812,092 | -$8.82M | 0 | 0 | 1 | 0 | 1 |
| MYGN | MYRIAD GENETICS INC | -783,141 | -$17.88M | 1 | 0 | 1 | 0 | 2 |
| WAT | WATERS CORP | -759,463 | -$145.00M | 1 | 1 | 2 | 0 | 4 |
| MTNB | MATINAS BIOPHARMA HOLDINGS I | -757,300 | -$409.00K | 0 | 0 | 1 | 0 | 1 |
| DGX | QUEST DIAGNOSTICS INC | -747,076 | -$58.25M | 1 | 1 | 0 | 2 | 2 |
| CPRX | CATALYST PHARMACEUTICALS INC | -739,226 | -$2.85M | 0 | 0 | 0 | 1 | 0 |
| JNJ | JOHNSON & JOHNSON | -672,639 | $108.84M | 4 | 5 | 9 | 1 | 22 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | -666,400 | -$19.17M | 0 | 0 | 0 | 1 | 0 |
| SAVA | CASSAVA SCIENCES INC | -653,759 | -$2.69M | 0 | 0 | 0 | 1 | 0 |
| GMED | GLOBUS MEDICAL INC - A | -634,400 | -$23.30M | 0 | 0 | 1 | 0 | 1 |
| OMI | OWENS & MINOR INC | -624,450 | -$9.40M | 0 | 0 | 1 | 0 | 1 |
| MRNA | MODERNA INC | -614,171 | -$5.10M | 2 | 0 | 0 | 2 | 2 |
| BKD | BROOKDALE SENIOR LIVING INC | -529,200 | -$3.82M | 0 | 0 | 1 | 0 | 1 |
| ALDX | ALDEYRA THERAPEUTICS INC | -516,782 | -$1.14M | 0 | 0 | 1 | 0 | 1 |
| RVNC | REVANCE THERAPEUTICS INC | -472,700 | -$7.00M | 0 | 0 | 0 | 1 | 0 |
| MGNX | MACROGENICS INC | -468,123 | -$2.72M | 0 | 0 | 0 | 1 | 0 |
| LGND | LIGAND PHARMACEUTICALS | -464,400 | -$28.47M | 0 | 0 | 1 | 0 | 1 |
| SAGE | SAGE THERAPEUTICS INC | -461,332 | -$9.57M | 0 | 0 | 1 | 0 | 1 |
| COR | CENCORA INC | -454,174 | -$29.45M | 1 | 1 | 2 | 1 | 4 |
| MRSN | MERSANA THERAPEUTICS INC | -443,300 | $3.39M | 0 | 0 | 1 | 0 | 1 |
Frequently asked questions about Most sold healthcare stocks in Q2 2020
What are the most sold Healthcare stocks in Q2 2020?
The most sold healthcare stocks in Q2 2020 are those with the largest decrease in reported share counts across institutional investors compared to Q1 2020, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q2 2020?
Among filers in this sector, net reductions were largest in companies such as BRISTOL-MYERS SQUIBB CO (BMY), BOSTON SCIENTIFIC CORP (BSX), ASTRAZENECA PLC-SPONS ADR (AZN), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q1 2020).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.